Search

everythinglearnresearchcommunity

for

Search:↓

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

DHT, a testosterone byproduct, causes male pattern baldness.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Certain medications and maintaining adequate iron levels can help manage women's hair loss.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Taking oral testosterone with finasteride or dutasteride doubles testosterone levels, and food slightly affects it.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

Male-pattern baldness might be caused by the effect of hormones on scalp blood vessels.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

Finasteride negatively affects fish reproduction and gonadal development.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Finasteride safely treats enlarged prostate and male-pattern baldness.

Compounds from the Sansevieria trifasciata plant might be effective for treating hair loss.